Online citations, reference lists, and bibliographies.
← Back to Search

Patterns Of Inpatient Care For Newly Diagnosed Immune Thrombocytopenia In US Children’s Hospitals

C. Kime, J. Klima, M. Rose, S. O'Brien
Published 2013 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
OBJECTIVE: Although recent evidence-based guidelines for the management of immune thrombocytopenia (ITP) recommend a conservative, observation-based approach for the majority of patients with newly diagnosed pediatric ITP, current practice patterns are unknown. This study used the Pediatric Health Information System database to examine patterns of inpatient care in newly diagnosed ITP in freestanding US children’s hospitals and to examine geographic differences in care. METHODS: Data were extracted from Pediatric Health Information System for all newly diagnosed ITP admissions aged 1 to 18 years discharged between January 2008 and December 2010. Clinical data obtained included age, gender, length of stay, diagnoses, medications, and discharge status. RESULTS: We identified 2314 unique patients meeting the study diagnosis of newly diagnosed ITP. Noncutaneous bleeding occurred in 12% of patients (intracranial hemorrhage 0.6%), with epistaxis the most commonly reported symptom. Ninety percent of hospitalized patients received ITP-directed therapy, with intravenous immunoglobulin G the most commonly used therapy (78% of patients). We identified significant variation by geographic region in treatment strategies, length of stay, hospital charges, and likelihood of readmission. CONCLUSIONS: A substantial number of children with newly diagnosed ITP continue to be hospitalized and receive intravenous medications, although the majority of these patients do not have clinical bleeding events during the admission. By using these results as a backdrop, future studies will be able to identify if the number of ITP admissions, costs of care, and geographic variability in care decrease with the dissemination and implementation of recently published guidelines.
This paper references
Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study
T. Kühne (2001)
Immune thrombocytopenic purpura.
I. Khouri (2002)
Health‐related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross‐sectional survey in China
Ze-ping Zhou (2007)
A cost‐utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP)
Sarah H. O'Brien (2007)
A costutility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP). Pediatr Blood Cancer
S H Oaposbrien (2007)
A costutility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP)
SH O’Brien (2007)
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura.
C. Neunert (2008)
Childhood immune thrombocytopenic purpura: diagnosis and management.
V. Blanchette (2008)
Intercontinental Childhood ITP Study Group Registry II Participants. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura
CE Neunert (2008)
Genetic studies in pediatric ITP: outlook, feasibility, and requirements
A. Bergmann (2009)
International consensus report on the investigation and management of primary immune thrombocytopenia.
D. Provan (2010)
In - ternational consensus report on the investigation and management of primary immune thrombocytopenia
D Provan (2010)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.
C. Neunert (2011)
Changing trends in the UK management of childhood ITP
J. Grainger (2011)
Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group
T. Kühne (2011)
Federating clinical data from six pediatric hospitals: process and initial results from the PHIS+ Consortium.
S. Narus (2011)
Analysis of Health-related Quality of Life in Children with Immune Thrombocytopenia and Their Parents Using the Kids’ ITP Tools
Rama Zilber (2012)
Merging of the National Cancer Institute–funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group
R. Aplenc (2012)
Copyright © 2013 by the American Academy of Pediatrics
Grove Village (2013)
Idiopathic thrombocytopenic purpura
L. Kayal (2014)

This paper is referenced by
ESPED survey on newly diagnosed immune thrombocytopenia in childhood: how much treatment do we give?
Hannah von Lukowicz (2021)
Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis
D. Weycker (2019)
Etiology, Management, and Outcome of Pediatric Epistaxis
T. Send (2019)
Toddler with Bruising on Knees
F. Rahmani (2019)
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.
D. Provan (2019)
A method for analyzing inpatient care variability through physicians' orders
Matthew C. Lenert (2019)
Breaking Down Blood: Pediatric Immune Thrombocytopenia and Autoimmune Hemolytic Anemia in the Emergency Department
Richard T Graham (2018)
Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
T. Güngör (2018)
Pediatric ITP: is it different from adult ITP?
J. Despotovic (2018)
Childhood immune thrombocytopenia: A nationwide cohort study on condition management and outcomes
L. Grimaldi‐Bensouda (2017)
Recent trends in practice patterns and comparisons between immunoglobulin and corticosteroid in pediatric immune thrombocytopenia
Y. Okubo (2017)
Patterns of Emergency Department Care for Newly Diagnosed Immune Thrombocytopenia in United States Children's Hospitals
L. Jones (2017)
Hospitalizations in pediatric patients with immune thrombocytopenia in the United States
M. Tarantino (2016)
When and how to treat childhood immune thrombocytopenia.
Jennifer Allen (2016)
Pediatric Immune Thrombocytopenia in Lebanon: Treatment and Predictors of Outcome
A. Inati (2016)
I When and how to treat childhood immune
A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Determine the Effect of Romiplostim on Health‐Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents
S. Mathias (2016)
Multicenter Cohort Study Comparing U.S. Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines
Char M. Witmer (2016)
Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP.
A. Frelinger (2015)
Acute Immune Thrombocytopenia Purpura
Erin Woodworth (2015)
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review
C. Neunert (2015)
An update on the use of immunoglobulin for the treatment of immunodeficiency disorders.
S. Albin (2014)
Influence of the American Society of Hematology guidelines on the management of newly diagnosed childhood immune thrombocytopenia.
Corinna L Schultz (2014)
Fifteen-minute consultation: investigation and management of childhood epistaxis
Somiah Siddiq (2014)
A review of the management of childhood immune thrombocytopenia: how can we provide an evidence‐based approach?
N. Cooper (2014)
Newly Diagnosed Immune Thrombocytopenia: Update on Diagnosis and Management
D. Bansal (2013)
Immune Thrombocytopenia (ITP)
B. Psaila (2013)
Semantic Scholar Logo Some data provided by SemanticScholar